A study found that curcumin combined with (−)-epigallocatechin-3-gallate (EGCG) reduced tumor growth and angiogenesis by inhibiting the JAK/STAT3/IL-8 signaling pathway in CRC [115]. The gene discussed is STAT3; the disease is colorectal carcinoma.